Mason Street Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-54,415
| Closed | -$186K | – | 1363 |
|
|
2020
Q4 | $186K | Sell |
54,415
-261
| -0.5% | -$1.07K | ﹤0.01% | 1427 |
|
|
2020
Q3 | $223K | Buy |
54,676
+11,578
| +27% | +$44K | ﹤0.01% | 1315 |
|
|
2020
Q2 | $146K | Buy |
43,098
+3,749
| +10% | +$10.9K | ﹤0.01% | 1400 |
|
|
2020
Q1 | $92K | Hold |
39,349
| – | – | ﹤0.01% | 1426 |
|
|
2019
Q4 | $143K | Buy |
39,349
+1,028
| +3% | +$8.31K | ﹤0.01% | 1448 |
|
|
2019
Q3 | $318K | Buy |
38,321
+2,816
| +8% | +$22.8K | 0.01% | 1248 |
|
|
2019
Q2 | $306K | Buy |
35,505
+1,624
| +5% | +$14.5K | 0.01% | 1248 |
|
|
2019
Q1 | $362K | Buy |
33,881
+2,339
| +7% | +$25K | 0.01% | 1238 |
|
|
2018
Q4 | $276K | Buy |
31,542
+2,252
| +8% | +$28.7K | 0.01% | 1233 |
|
|
2018
Q3 | $492K | Buy |
29,290
+2,246
| +8% | +$48.6K | 0.01% | 1101 |
|
|
2018
Q2 | $567K | Buy |
27,044
+1,912
| +8% | +$35.4K | 0.01% | 1027 |
|
|
2018
Q1 | $404K | Buy |
25,132
+1,569
| +7% | +$31.1K | 0.01% | 1112 |
|
|
2017
Q4 | $447K | Buy |
23,563
+4,302
| +22% | +$77.9K | 0.01% | 1065 |
|
|
2017
Q3 | $271K | Buy |
19,261
+1,811
| +10% | +$16.4K | 0.01% | 1226 |
|
|
2017
Q2 | $130K | Buy |
17,450
+873
| +5% | +$5.7K | ﹤0.01% | 1401 |
|
|
2017
Q1 | $108K | Buy |
16,577
+1,279
| +8% | +$7.15K | ﹤0.01% | 1428 |
|
|
2016
Q4 | $68K | Buy |
15,298
+766
| +5% | +$3.21K | ﹤0.01% | 1470 |
|
|
2016
Q3 | $68K | Buy |
14,532
+2,624
| +22% | +$15.5K | ﹤0.01% | 1449 |
|
|
2016
Q2 | $78K | Buy |
11,908
+1,374
| +13% | +$9.71K | ﹤0.01% | 1410 |
|
|
2016
Q1 | $67K | Buy |
10,534
+983
| +10% | +$5.04K | ﹤0.01% | 1412 |
|
|
2015
Q4 | $58K | Buy |
9,551
+824
| +9% | +$4.71K | ﹤0.01% | 1419 |
|
|
2015
Q3 | $52K | Buy |
8,727
+583
| +7% | +$4.05K | ﹤0.01% | 1423 |
|
|
2015
Q2 | $56K | Buy |
8,144
+460
| +6% | +$2.92K | ﹤0.01% | 1430 |
|
|
2015
Q1 | $47K | Buy |
7,684
+243
| +3% | +$1.62K | ﹤0.01% | 1452 |
|
|
2014
Q4 | $52K | Buy |
7,441
+223
| +3% | +$1.64K | ﹤0.01% | 1835 |
|
|
2014
Q3 | $59K | Buy |
7,218
+293
| +4% | +$2.29K | ﹤0.01% | 1795 |
|
|
2014
Q2 | $56K | Buy |
6,925
+228
| +3% | +$1.73K | ﹤0.01% | 1797 |
|
|
2014
Q1 | $53K | Sell |
6,697
-1,838
| -22% | -$15.6K | ﹤0.01% | 1784 |
|
|
2013
Q4 | $76K | Buy |
8,535
+717
| +9% | +$6.4K | ﹤0.01% | 1765 |
|
|
2013
Q3 | $66K | Buy |
7,818
+582
| +8% | +$4.71K | ﹤0.01% | 1640 |
|
|
2013
Q2 | $54K | Buy |
+7,236
| New | +$55.5K | ﹤0.01% | 1596 |
|
Other funds holding SPPI
AC
ACM
Mason Street Advisors's SPPI Position: Q1 2021 in Review
Mason Street Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2021, closing a stake of 54,415 shares — an estimated $186K sold.
Mason Street Advisors first reported a position in SPPI in Q2 2013 and held it in 31 quarters. The position peaked at $567K in Q2 2018. 147 funds tracked by Wall St. Rank hold SPPI as of Q1 2021.
- Mason Street Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 54,415 Spectrum Pharmaceuticals Inc shares in Q1 2021, an estimated $186K.
- Mason Street Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Spectrum Pharmaceuticals Inc position peaked at $567K in Q2 2018.
- 147 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.